Knight Therapeutics Inc.
GUD.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.30K | -1.42M | -3.37M | -17.88M | 7.15M |
| Total Depreciation and Amortization | 9.82M | 9.62M | 9.33M | 7.77M | 10.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | 648.30K | -- |
| Total Other Non-Cash Items | 1.86M | -278.40K | 5.44M | 18.76M | -659.80K |
| Change in Net Operating Assets | -8.06M | -8.72M | 11.50M | 3.89M | -5.39M |
| Cash from Operations | 3.68M | -793.70K | 22.91M | 13.19M | 11.31M |
| Capital Expenditure | -274.20K | -502.80K | -673.50K | -324.10K | -169.20K |
| Sale of Property, Plant, and Equipment | -- | 2.20K | 43.00K | 1.41M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.73M | 9.09M | -17.44M | -2.49M | 26.83M |
| Cash from Investing | 8.45M | 8.59M | -18.07M | -1.40M | 26.66M |
| Total Debt Issued | 1.64M | 747.00K | 545.00K | 0.00 | 2.71M |
| Total Debt Repaid | -3.04M | -7.91M | -2.61M | -12.09M | -3.35M |
| Issuance of Common Stock | 448.00K | 340.00K | 74.00K | 95.00K | 88.00K |
| Repurchase of Common Stock | -2.47M | -1.24M | -- | -19.08M | -9.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -503.00K | -3.30M | -905.00K | -4.62M | -850.00K |
| Cash from Financing | -2.88M | -8.30M | -2.15M | -26.24M | -8.38M |
| Foreign Exchange rate Adjustments | 243.40K | -974.20K | 338.20K | 734.30K | -81.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.49M | -1.48M | 3.02M | -13.71M | 29.50M |
